Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Paeschke

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 6, 2017
[Current cases of falsified medicinal products within the competence of the Federal Institute for Drugs and Medical Devices (BfArM) : Case studies and extent]Marcus Wittstock, Norbert Paeschke
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 26, 2017
[Counterfeit medicines]Brigitte Keller-Stanislawski, Norbert Paeschke
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|August 8, 2018
[Educational material as part of risk minimisation]Lothar Heymans, Martin Huber, Norbert Paeschke, et al.
Deutsches Arzteblatt International|July 2, 2018
Frequent Adverse Drug Reactions, and Medication Groups under SuspicionDiana Dubrall, Matthias Schmid, Eva Alešik, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|April 26, 2022
[Instruments of official communication by regulatory authorities on risks of drug use]Simone Bergner, Thomas Grüger, Martin Huber, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 6, 2017
[Current cases of falsified medicinal products within the competence of the Federal Institute for Drugs and Medical Devices (BfArM) : Case studies and extent]Marcus Wittstock, Norbert Paeschke
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 26, 2017
[Counterfeit medicines]Brigitte Keller-Stanislawski, Norbert Paeschke
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|August 8, 2018
[Educational material as part of risk minimisation]Lothar Heymans, Martin Huber, Norbert Paeschke, et al.
Deutsches Arzteblatt International|July 2, 2018
Frequent Adverse Drug Reactions, and Medication Groups under SuspicionDiana Dubrall, Matthias Schmid, Eva Alešik, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|April 26, 2022
[Instruments of official communication by regulatory authorities on risks of drug use]Simone Bergner, Thomas Grüger, Martin Huber, et al.
Pageof 1